RheumNow Podcast - 60/40/20 Interview with Dr. Ed Keystone

Save

Dr. Jack Cush interviews Professor Edward Keystone, MD (University of Toronto) on the origins and science behind the 60/40/20 benchmark and outcomes in rheumatoid arthritis.

Read Article

Risankizumab for Active Psoriatic Arthritis

Save

The arsenal of therapeutics for psoriatic arthritis continues to increase. Risankizumab is an IL-23 inhibitor to the p19 subunit, currently being investigated for treatment of psoriatic arthritis.

Read Article

Better assessment and management of multimorbidity

Save

Appropriate assessment and management of comorbidities and multimorbidity in patients with RA is vital for overall health and well-being of the patient, as well as to encourage treatment adherence, and address social, psychological and quality of life factors. 

Read Article

Food for Thought: "ITIS" Diet for Patients with Rheumatoid Arthritis: Dr. Akhil Sood ( @AkhilSoodMD) discusses abstract #1699 presented at the ACR21 annual meeting.https://t.co/wSPuGimFjP https://t.co/nc7bg1Odjk

Infection Risk in Offspring Exposed to Biologics: Dr. Rachel Tate ( @uptoTate)https://t.co/oYpKpCix7Q https://t.co/0yIk9Qhc1h

Multimorbidity, the presence of multiple overlapping chronic comorbid conditions, is increasingly common at first presentation of rheumatoid arthritis (RA), increasing as a person gets older and/or during disease progression. https://t.co/L6NJhVwOws https://t.co/GgRSCaYTZ6

"The reasonable man adapts himself to the world; the unreasonable one persists in trying to adapt the world to himself. Therefore, all progress depends on the unreasonable man." - George Bernard Shaw https://t.co/9bAJfkF7lH

Safety of Psoriatic Biologics in Pregnancy

Save

Little is known about the safety of newer biologic use during pregnancy, especially in patients who either conceive while on a biologic or must remain on a biologic during pregnancy (often the case with IBD and inflammatory arthritis).

Read Article

Emerging Therapies in Spondyloarthritis: A Promising Pipeline

Save

Growing awareness of spondyloarthropathies over the last two decades has led to a better understanding of the pathophysiology of spondyloarthritis, and subsequently increased interest in more distinct, disease state specific treatment options.

Read Article

Flare Patterns in Autoinflammatory Syndrome During Pandemic: Dr. Yuz Yusof ( @Yuz6Yusof) discusses abstract #1083 presented at the #ACR21 annual meeting.https://t.co/i0VU3NEe7F https://t.co/DZkB5TgG3N

RA Treatment Conundrums: Dr. Janet Pope ( @Janetbirdope ) reviews abstracts #1252, #1442, #1438, #1444 and #1443 at the #ACR21 annual meeting.https://t.co/ftlRAq0CNK https://t.co/nnT37wG8l9

Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of labs in infections vs. flares Drs.Cush, Yusof, Mehta, Petryna and Tate review autoinflammatory data presented at #ACR21. @Yuz6Yusof @bella_mehta @DrPetryna @uptoTate https://t.co/oeAprkSBWZ https://t.co/1g9yRRFJqf

SLE and Health-Related Quality of Life: Dr. Sheila Reyes ( @RHEUMarampa) discusses abstract #1261 presented at the #ACR21 annual meeting.https://t.co/yLPBfId6tL https://t.co/09U4nUT9c7

FDA Session Review: Dr. Arthur Kavanaugh discussed the FDA session presented at the ACR21meeting, including safety data and new approvals and indications in several rheumatic diseases, including lupus, ANCA-associated vasculitis, lupus nephritis and more.https://t.co/5YkbzDv0YR https://t.co/MS9KNIfm2m

The Last CBD Trial: Dr. David Liew ( @drdavidliew) discusses abstract #1456 presented at the #ACR21 annual meeting.https://t.co/Kw3h2vTJkv https://t.co/WZGV7iOFlA

Does Control of Inflammation Lower Cancer Risk? https://t.co/9dHwXmzktZ https://t.co/iPP09Bk3P3